Ximed develops radio frequency (RF) needles for fibroid myolysis:
This article was originally published in Clinica
Executive Summary
Ximed Medical of California has announced a range of retractable radio frequency needle products for laparoscopic and hysteroscopic myolysis - the ablation of uterine fibroids. The needles monitor tissue impedance and current delivery during ablation, providing audible and visual feedback to the surgeon. They will be marketed by Gynus Medical.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.